Page last updated: 2024-08-25

rosiglitazone and Abscess

rosiglitazone has been researched along with Abscess in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, CH; Chen, PC; Chuang, LM; Dong, YH; Ko, WC; Wang, JL; Wu, LC	1
Joshi, GS; Richardson, AR; Thurlow, LR	1

Other Studies

2 other study(ies) available for rosiglitazone and Abscess

Article	Year
Thiazolidinediones and reduced risk of incident bacterial abscess in adults with type 2 diabetes: A population-based cohort study. Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:12 Topics: Abscess; Adult; Aged; Databases, Factual; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Incidence; Liver Abscess; Male; Metformin; Middle Aged; National Health Programs; Pioglitazone; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Taiwan; Thiazolidinediones; Treatment Outcome	2018
Peroxisome Proliferator-Activated Receptor γ Is Essential for the Resolution of Staphylococcus aureus Skin Infections. Cell host & microbe, 2018, 08-08, Volume: 24, Issue:2 Topics: Abscess; Animals; Female; Glucose; Host-Pathogen Interactions; Male; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred C57BL; Mice, Transgenic; PPAR gamma; Rosiglitazone; Staphylococcal Skin Infections	2018

Article

Year

Thiazolidinediones and reduced risk of incident bacterial abscess in adults with type 2 diabetes: A population-based cohort study.

Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:12

Topics: Abscess; Adult; Aged; Databases, Factual; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Incidence; Liver Abscess; Male; Metformin; Middle Aged; National Health Programs; Pioglitazone; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Taiwan; Thiazolidinediones; Treatment Outcome

2018

Peroxisome Proliferator-Activated Receptor γ Is Essential for the Resolution of Staphylococcus aureus Skin Infections.

Cell host & microbe, 2018, 08-08, Volume: 24, Issue:2

Topics: Abscess; Animals; Female; Glucose; Host-Pathogen Interactions; Male; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred C57BL; Mice, Transgenic; PPAR gamma; Rosiglitazone; Staphylococcal Skin Infections

2018